CSIMarket
 


Quest Diagnostics Inc  (DGX)
Other Ticker:  
 
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare
 

DGX's Revenue Growth by Quarter and Year

Quest Diagnostics Inc's Revenue results by quarter and year




DGX Revenue (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December - 2,333.00 2,744.00 3,002.00
III Quarter September - 2,486.00 2,774.00 2,786.00
II Quarter June 2,338.00 2,453.00 2,550.00 1,827.00
I Quarter March 2,331.00 2,611.00 2,720.00 1,822.00
FY   4,669.00 9,883.00 10,788.00 9,437.00



DGX Revenue second quarter 2023 Y/Y Growth Comment
Quest Diagnostics Inc reported decrease in Revenue in the second quarter 2023 by -4.69% to $ 2,338.00 millions, from the same quarter in 2022.
The decrease in the second quarter 2023 Quest Diagnostics Inc's Revenue compares unfavorably to the Company's average Revenue growth of 4.09%.

Looking into second quarter 2023 results within Medical Laboratories industry 6 other companies have achieved higher Revenue growth. While Quest Diagnostics Inc' s Revenue decline of -4.69% ranks overall at the positon no. 1022 in the second quarter 2023.




DGX Revenue ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter December - -14.98 % -8.59 % 55.87 %
III Quarter September - -10.38 % -0.43 % 42.43 %
II Quarter June -4.69 % -3.8 % 39.57 % -6.45 %
I Quarter March -10.72 % -4.01 % 49.29 % -3.65 %
FY   - -8.39 % 14.32 % 22.15 %

Financial Statements
Quest Diagnostics Inc's second quarter 2023 Revenue $ 2,338.00 millions DGX's Income Statement
Quest Diagnostics Inc's second quarter 2022 Revenue $ 2,453.00 millions Quarterly DGX's Income Statement
New: More DGX's historic Revenue Growth >>


DGX Revenue (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter December - -6.15 % -1.08 % 7.75 %
III Quarter September - 1.35 % 8.78 % 52.49 %
II Quarter June 0.3 % -6.05 % -6.25 % 0.27 %
I Quarter March -0.09 % -4.85 % -9.39 % -5.4 %
FY (Year on Year)   - -8.39 % 14.32 % 22.15 %




Revenue second quarter 2023 Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #7
Healthcare Sector #113
Overall #1022

Revenue Y/Y Growth Statistics
High Average Low
46.83 % 4.09 % -10.34 %
(Jun 30 2021)   (Jun 30 2023)
Revenue second quarter 2023 Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #7
Healthcare Sector #113
Overall #1022
Revenue Y/Y Growth Statistics
High Average Low
46.83 % 4.09 % -10.34 %
(Jun 30 2021)   (Jun 30 2023)

Revenue by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Quest Diagnostics Inc's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
52.49 % 1.05 % -9.39 %
(Sep 30 2020)  


DGX's II. Quarter Q/Q Revenue Comment
Quest Diagnostics Inc achieved in the II. Quarter 2023 below company average Revenue growth of 0.3% quarter on quarter, to $ 2,338.00 millions.

II. Quarter 2023 DGX's performance seem to be paradoxical, even if below the average growth of 1.05 %, yet it presents absolute recovery compare to the -6.05% in the same quarter a year ago

Within Medical Laboratories industry 8 other companies have achieved higher Revenue quarter on quarter growth. While Quest Diagnostics Inc's Revenue growth quarter on quarter, overall rank is 857.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Laboratories Industry #9
Healthcare Sector #128
Overall #857
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Laboratories Industry #9
Healthcare Sector #128
Overall #857
Revenue Q/Q Growth Statistics
High Average Low
52.49 % 1.05 % -9.39 %
(Sep 30 2020)  


DGX's II. Quarter Q/Q Revenue Comment
Quest Diagnostics Inc achieved in the II. Quarter 2023 below company average Revenue growth of 0.3% quarter on quarter, to $ 2,338.00 millions.

Although the II. Quarter 2023 DGX's Revenue sequential growth was beneath the ordinary , it was yet encouraging story, as the II. Quarter improvement, outshines the -6.05% rise in the same quarter a year ago

Within Medical Laboratories industry 8 other companies have achieved higher Revenue quarter on quarter growth. While Quest Diagnostics Inc's Revenue growth quarter on quarter, overall rank is 857.


Quest Diagnostics Inc's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
12 Months Ending
(Sep 30 2022)
12 Months Ending
(Jun 30 2022)
Cumulative Revenue 12 Months Ending $ 9,488.00 $ 9,603.00 $ 9,883.00 $ 10,294.00 $ 10,582.00
Y / Y Revenue Growth (TTM) -10.34 % -10.08 % -8.39 % -6.81 % -4.3 %
Year on Year Revenue Growth Overall Ranking # 1095 # 349 # 1007 # 2148 # 125
Seqeuential Revenue Change (TTM) -1.2 % -2.83 % -3.99 % -2.72 % -0.91 %
Seq. Revenue Growth (TTM) Overall Ranking # 1022 # 409 # 1933 # 119 # 1829




Cumulative Revenue growth Comment
Quest Diagnostics Inc's cumulative 12 months Revenue continue to decline, but on the faster rate at -10.34% year on year, at Jun 30 2023 compare to the -10.08% decrease at Mar 31 2023. If the Quest Diagnostics Inc's fiscal year would end at Jun 30 2023, annual Revenue would be $9,488 millions.

In the Healthcare sector 120 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 349 to 1095.

Revenue TTM Q/Q Growth Statistics
High Average Low
46.83 %
4.09 %
-10.34 %
 

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry # 7
Healthcare Sector # 121
Overall # 1095

Revenue TTM Y/Y Growth Statistics
High Average Low
46.83 %
4.09 %
-10.34 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 7
Sector # 113
S&P 500 # 1022
Cumulative Revenue growth Comment
Quest Diagnostics Inc's cumulative 12 months Revenue continue to decline, but on the faster rate at -10.34% year on year, at Jun 30 2023 compare to the -10.08% decrease at Mar 31 2023. If the Quest Diagnostics Inc's fiscal year would end at Jun 30 2023, annual Revenue would be $9,488 millions.

In the Healthcare sector 120 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 349 to 1095.

Revenue TTM Q/Q Growth Statistics
High Average Low
46.83 %
4.09 %
-10.34 %
 


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry # 7
Healthcare Sector # 121
Overall # 1095

Revenue TTM Y/Y Growth Statistics
High Average Low
46.83 %
4.09 %
-10.34 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 7
Sector # 113
S&P 500 # 1022




Other Revenue Growth
Medical Laboratories Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
DGX's Revenue Growth Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for DGX's Competitors
Revenue Growth for Quest Diagnostics Inc's Suppliers
Revenue Growth for DGX's Customers

You may also want to know
DGX's Annual Growth Rates DGX's Profitability Ratios DGX's Asset Turnover Ratio DGX's Dividend Growth
DGX's Roe DGX's Valuation Ratios DGX's Financial Strength Ratios DGX's Dividend Payout Ratio
DGX's Roa DGX's Inventory Turnover Ratio DGX's Growth Rates DGX's Dividend Comparisons



Companies with similar Revenue decline for the quarter ending Jun 30 2023 within Healthcare SectorY/Y Change %Revenue for the quarter ending Jun 30 2023
Aquestive Therapeutics Inc -0.18%$ -0.181 millions
Phibro Animal Health Corporation-0.34%$ -0.340 millions
Amedisys Inc-0.88%$ -0.882 millions
Baxter International Inc -1.04%$ -1.041 millions
Healthcare Services Group Inc -1.39%$ -1.395 millions
Bio rad Laboratories Inc -1.54%$ -1.536 millions
Harvard Bioscience Inc-1.83%$ -1.832 millions
Embecta Corp -1.92%$ -1.924 millions
Enhabit Inc -2.13%$ -2.127 millions
Icu Medical Inc-2.26%$ -2.260 millions
Tandem Diabetes Care Inc -2.26%$ -2.261 millions
West Pharmaceutical Services Inc -2.27%$ -2.269 millions
Coherus Biosciences inc -2.39%$ -2.386 millions
Hookipa Pharma inc -2.44%$ -2.440 millions
Biolife Solutions Inc -2.53%$ -2.529 millions
Inspiremd Inc -2.61%$ -2.613 millions
Enanta Pharmaceuticals Inc-3.01%$ -3.014 millions
National Research Corporation-3.03%$ -3.033 millions
Intellia Therapeutics Inc -3.11%$ -3.108 millions
Orgenesis Inc -3.14%$ -3.138 millions
Organogenesis Holdings Inc -3.36%$ -3.365 millions
Marker Therapeutics inc -3.52%$ -3.523 millions
Akumin Inc -3.79%$ -3.793 millions
Endo International Plc-3.91%$ -3.912 millions
Zimvie Inc -4.12%$ -4.122 millions
Integra Lifesciences Holdings Corp-4.16%$ -4.160 millions
Universal Biosensors Inc -4.18%$ -4.177 millions
Sonendo Inc -4.26%$ -4.257 millions
Avinger Inc -4.27%$ -4.268 millions
Fuse Medical Inc -4.27%$ -4.271 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com